Molecular Innovations, Inc.

Southfield, MI 48304

SBIR Award Summary

Total Number of Awards 4
Total Value of Awards $1.07MM
First Award Date 01/01/02
Most Recent Award Date 03/17/10

Key Personnel

Last Name Name Awards Contact
Day Duane Ellington Day 4

4 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-080
Budget: 03/17/10 - 12/31/11

DESCRIPTION (provided by applicant): This Phase I proposal will seek to fully develop a prototype assay for the measurement of human prorenin levels through the use of a unique monoclonal antibody developed in our laboratory that detects an epitope of the human renin prosegment. Recent literature, as well as clinical studies suggests a very stro...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/04 - 08/31/06

DESCRIPTION (provided by applicant): Neutrophil elastase and cathepsin G are serine proteases stored within the primary granules of neutrophils. The activation and degranulation of neutrophils at inflammatory sites result in the release of these proteases where they encounter inhibitors that regulate their activity in certain inflammatory condit...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/19/03 - 08/31/04

DESCRIPTION (provided by applicant): Neutrophil elastase and cathepsin G are serine proteases stored within the primary granules of neutrophils. The activation and degranulation of neutrophils at inflammatory sites result in the release of these proteases where they encounter inhibitors that regulate their activity in certain inflammatory condit...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 01/01/02 - 09/30/02

DESCRIPTION (provided by applicant): This proposal aims to examine the feasibility of using plasminogen activator inhibitor type 1 (PaI-i) mutants as inhibitors of the neutrophil proteinases, neutrophil elastase and cathepsin G. Native PAI-i is not an inhibitor of neutrophil enzymes but preliminary studies present...